These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4212805)

  • 21. Blockade of apomorphine-induced aggression by morphine or neuroleptics: differential alteration by antimuscarinics and naloxone.
    Gianutsos G; Lal H
    Pharmacol Biochem Behav; 1976 Jun; 4(6):639-42. PubMed ID: 988593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonistic effects of neuroleptics and apomorphine on synaptosomal tyrosine hydroxylase in vitro.
    Christiansen J; Squires RF
    J Pharm Pharmacol; 1974 Sep; 26(9):742-3. PubMed ID: 4155757
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction between GABA agonists and the cholinergic muscarinic system in rat corpus striatum.
    Ferkany JW; Enna SJ
    Life Sci; 1980 Jul; 27(2):143-9. PubMed ID: 7401929
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of the serotonin2-receptors in regulation of aggressive behavior.
    Vasar EE; Maimets MO; Allikmets LKh
    Neurosci Behav Physiol; 1986; 16(2):118-24. PubMed ID: 3748368
    [No Abstract]   [Full Text] [Related]  

  • 26. Dopaminergic inhibition of striatal cholinergic neurons: synergistic blocking action of gamma-butyrolactone and neuroleptic drugs.
    Stadler H; Lloyd KG; Bartholini G
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(2):129-34. PubMed ID: 4369933
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition and potentiation of apomorphine-induced hypermotility in rats by neuroleptics.
    Lassen JB
    Eur J Pharmacol; 1976 Apr; 36(2):385-93. PubMed ID: 1278230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of neuroleptic and muscarinic agents with central dopaminergic systems.
    Kelly PH; Miller RJ
    Br J Pharmacol; 1975 May; 54(1):115-21. PubMed ID: 1139072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system.
    Pycock C; Milson J; Tarsy D; Marsden CD
    Neuropharmacology; 1978 Mar; 17(3):175-83. PubMed ID: 565479
    [No Abstract]   [Full Text] [Related]  

  • 30. Correlation between catalepsy and dopamine decrease in the rat striatum induced by neuroleptics.
    Honma T; Fukushima H
    Neuropharmacology; 1976 Oct; 15(10):601-7. PubMed ID: 1033478
    [No Abstract]   [Full Text] [Related]  

  • 31. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum.
    Protais P; Costentin J; Schwartz JC
    Psychopharmacology (Berl); 1976 Oct; 50(1):1-6. PubMed ID: 827755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of a 'cholinergic link' in the apomorphine-induced feedback inhibition of dopamine synthesis in rat striatum.
    Van Zwieten-Boot BJ; Petri-Bot A
    Eur J Pharmacol; 1976 Oct; 39(2):245-50. PubMed ID: 976319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ontogenesis of neostriatal cholinergic neurones in the rat and development of their sensitivity to neuroleptic drugs.
    Guyenet PG; Beaujouan JC; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(2-3):329-34. PubMed ID: 1161052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of neuroleptics and of combinations of d-amphetamine and neuroleptics on 3H-dopamine uptake by homogenates from rat striatum.
    Del Rio J; Madroñal J
    Eur J Pharmacol; 1976 Oct; 39(2):267-74. PubMed ID: 976322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors.
    Van Rossum JM
    Mod Probl Pharmacopsychiatry; 1970; 5():65-7. PubMed ID: 5527171
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacology and physiology of stereotyped behavior.
    Randrup A; Munkvad I
    J Psychiatr Res; 1974; 11():1-10. PubMed ID: 4218871
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical implications of dopaminergic and cholinergic effects of neuroleptic drugs.
    Stimmel GL
    Hosp Pharm; 1976 Feb; 11(2):50-1, 54-6. PubMed ID: 10235740
    [No Abstract]   [Full Text] [Related]  

  • 38. Adrenergic effect of chronic administration of neuroleptics.
    Schelkunov EL
    Nature; 1967 Jun; 214(5094):1210-2. PubMed ID: 6066102
    [No Abstract]   [Full Text] [Related]  

  • 39. [The biochemical effects of a new antidepressive, metapramine (RP 19560) on activity of the dopaminergic and cholinergic systems of the rat striatum].
    Boireau A; Garret C; Blanchard JC
    J Pharmacol; 1986; 17(1):75-84. PubMed ID: 2872367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates.
    Iversen LL; Horn AS; Miller RJ
    Adv Neurol; 1975; 9():197-212. PubMed ID: 167565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.